Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 10, 2026

Total Value ($000): $478,916 (100.0% shares, 0.0% debt)

Holdings (13)

New Positions (1)

URGN Urogen Pharma Ltd. (URGN) 0.5%

Value ($000) $2,529 Shares 108,000 Est. Cost $21.69 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
URGN	Urogen Pharma Ltd. (URGN)	108,000	$2,529	0.5%	$21.69	0.0%	COM	M96088105

Exited Positions (2)

— Verona Pharma plc (VRNA) 13.7%

Value ($000) $65,664 Shares 615,352 Est. Cost $7.38 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 2.3%

Value ($000) $10,954 Shares 2,960,659 Est. Cost $9.98 Unrealized -37.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Verona Pharma plc (VRNA)	615,352	$65,664	13.7%	$7.38	—	—	925050106
NUVB	Nuvation Bio Inc. (NUVB)	2,960,659	$10,954	2.3%	$9.98	-37.9%	—	67080N101

Decreased Positions (1)

BBIO BridgeBio Pharma Inc. (BBIO) 81.3%

Value ($000) $389,304 (+23.1%) Shares 5,089,611 (-16.4%) Est. Cost $40.43 Unrealized +62.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	5,089,611 (-16.4%)	$389,304 (+23.1%)	81.3%	$40.43	+62.4%	COM	10806X102

Unchanged Positions (11)

GLUE Monte Rosa Therapeutics Inc (GLUE) 4.8%

Value ($000) $23,086 Shares 1,472,331 Est. Cost $20.37 Unrealized -33.8%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 5.8%

Value ($000) $27,666 Shares 1,316,806 Est. Cost $10.41 Unrealized +67.6%

CALC CalciMedica, Inc. (CALC) 0.7%

Value ($000) $3,434 Shares 521,114 Est. Cost $4.55 Unrealized -14.2%

BMEA Biomea Fusion Inc (BMEA) 0.5%

Value ($000) $2,540 Shares 2,048,757 Est. Cost $8.06 Unrealized -82.6%

CMPS Compass Pathways Plc (CMPS) 1.7%

Value ($000) $8,269 Shares 1,198,418 Est. Cost $6.51 Unrealized —

BCAX Bicara Therapeutics Inc. (BCAX) 2.0%

Value ($000) $9,575 Shares 568,919 Est. Cost $25.50 Unrealized -33.0%

BBOT BridgeBio Oncology Therapeutics (BBOT) 1.5%

Value ($000) $7,069 Shares 564,625 Est. Cost $11.58 Unrealized —

SRRK Scholar Rock Holding Corporation (SRRK) 0.7%

Value ($000) $3,393 Shares 77,031 Est. Cost $34.98 Unrealized +7.2%

ACRS Aclaris Therapeutics Inc (ACRS) 0.3%

Value ($000) $1,308 Shares 434,455 Est. Cost $10.31 Unrealized -75.5%

MRKR Marker Therapeutics, Inc. (MRKR) 0.1%

Value ($000) $485 Shares 325,370 Est. Cost $1.80 Unrealized -37.1%

OKUR OnKure Therapeutics, Inc. (OKUR) 0.1%

Value ($000) $257 Shares 88,607 Est. Cost $15.14 Unrealized -80.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$23,086	4.8%	$20.37	-33.8%	COM	61225M102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,316,806	$27,666	5.8%	$10.41	+67.6%	COM	87164F105
CALC	CalciMedica, Inc. (CALC)	521,114	$3,434	0.7%	$4.55	-14.2%	COM NEW	38942Q202
BMEA	Biomea Fusion Inc (BMEA)	2,048,757	$2,540	0.5%	$8.06	-82.6%	COM	09077A106
CMPS	Compass Pathways Plc (CMPS)	1,198,418	$8,269	1.7%	$6.51	—	SPONSORED ADS	20451W101
BCAX	Bicara Therapeutics Inc. (BCAX)	568,919	$9,575	2.0%	$25.50	-33.0%	COM	055477103
BBOT	BridgeBio Oncology Therapeutics (BBOT)	564,625	$7,069	1.5%	$11.58	—	COM NEW	107924102
SRRK	Scholar Rock Holding Corporation (SRRK)	77,031	$3,393	0.7%	$34.98	+7.2%	COM	80706P103
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$1,308	0.3%	$10.31	-75.5%	COM	00461U105
MRKR	Marker Therapeutics, Inc. (MRKR)	325,370	$485	0.1%	$1.80	-37.1%	COM NEW	57055L206
OKUR	OnKure Therapeutics, Inc. (OKUR)	88,607	$257	0.1%	$15.14	-80.2%	COM CL A	68277Q105